Literature DB >> 12706246

GABAB receptor subunits, R1 and R2, in brainstem catecholamine and serotonin neurons.

Kathleen J Burman1, Antoinette O Ige, Julia H White, Fiona H Marshall, Menelas N Pangalos, Piers C Emson, Jane B Minson, Ida J Llewellyn-Smith.   

Abstract

GABA(B) receptors have been implicated in the GABAergic modulation of catecholaminergic and serotonergic pathways in the central nervous system. The GABA(B) receptor may require two subunits, GABA(B)R1 and GABA(B)R2, for functional activity. Using dual immunofluorescent labelling on adjacent cryostat sections, we investigated the presence of immunoreactivity for the GABA(B)R1 and GABA(B)R2 subunits in brainstem catecholamine (tyrosine hydroxylase-immunoreactive) and serotonin (tryptophan hydroxylase-immunoreactive) neurons. All neurons (>98%) examined in catecholamine groups A1, A2, A5, A6, C1, and serotonin groups B1-3 and B6-8 were immunoreactive for the GABA(B)R1 subunit. All A5 and A6 neurons (>97%) and at least 86% of A1, A2, C1, B2, B3, B7 and B8 neurons examined were GABA(B)R2-immunoreactive. The proportion of neurons with immunoreactivity for the GABA(B)R2 subunit varied between 0% and 99% for B1 neurons, and between 35% and 93% for B6 neurons. Statistical analysis showed that similar proportions of sampled neurons were immunoreactive for GABA(B)R1 and GABA(B)R2 in the A1, A5, A6, C1, B2 and B7 cell groups, whereas a smaller proportion of A2, B1, B3, B6 and B8 neurons were GABA(B)R2-immunoreactive than GABA(B)R1-immunoreactive. In general, our results suggest that GABA(B)R1 and GABA(B)R2 co-exist in the great majority of brainstem catecholamine and serotonin neurons. In the neurons that lack GABA(B)R2, the GABA(B)R1 subunit may act alone or with another protein.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12706246     DOI: 10.1016/s0006-8993(02)04269-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

1.  Increased GABA B receptor subtype expression in the nucleus of the solitary tract of the spontaneously hypertensive rat.

Authors:  Emma J Spary; Azhar Maqbool; Sikha Saha; Trevor F C Batten
Journal:  J Mol Neurosci       Date:  2008-03-13       Impact factor: 3.444

2.  Differential sensitivity to the motor and hypothermic effects of the GABA B receptor agonist baclofen in various mouse strains.

Authors:  Laura H Jacobson; John F Cryan
Journal:  Psychopharmacology (Berl)       Date:  2005-01-25       Impact factor: 4.530

3.  Redistribution of GABAB(1) protein and atypical GABAB responses in GABAB(2)-deficient mice.

Authors:  Martin Gassmann; Hamdy Shaban; Réjan Vigot; Gilles Sansig; Corinne Haller; Samuel Barbieri; Yann Humeau; Valérie Schuler; Matthias Müller; Bernd Kinzel; Klaus Klebs; Markus Schmutz; Wolfgang Froestl; Jakob Heid; Peter H Kelly; Clive Gentry; Anne-Lise Jaton; Herman Van der Putten; Cédric Mombereau; Lucas Lecourtier; Johannes Mosbacher; John F Cryan; Jean-Marc Fritschy; Andreas Lüthi; Klemens Kaupmann; Bernhard Bettler
Journal:  J Neurosci       Date:  2004-07-07       Impact factor: 6.167

4.  Immunoreactivity for the NMDA NR1 subunit in bulbospinal catecholamine and serotonin neurons of rat ventral medulla.

Authors:  Ida J Llewellyn-Smith; Patrick J Mueller
Journal:  Auton Neurosci       Date:  2013-04-04       Impact factor: 3.145

5.  Efferent projections of neuropeptide Y-expressing neurons of the dorsomedial hypothalamus in chronic hyperphagic models.

Authors:  Shin J Lee; Melissa Kirigiti; Sarah R Lindsley; Alberto Loche; Christopher J Madden; Shaun F Morrison; M Susan Smith; Kevin L Grove
Journal:  J Comp Neurol       Date:  2013-06-01       Impact factor: 3.215

6.  Postnatal changes in tryptophan hydroxylase and serotonin transporter immunoreactivity in multiple brainstem nuclei of the rat: implications for a sensitive period.

Authors:  Qiuli Liu; Margaret T T Wong-Riley
Journal:  J Comp Neurol       Date:  2010-04-01       Impact factor: 3.028

7.  Structures of metabotropic GABAB receptor.

Authors:  Makaía M Papasergi-Scott; Michael J Robertson; Alpay B Seven; Ouliana Panova; Jesper M Mathiesen; Georgios Skiniotis
Journal:  Nature       Date:  2020-06-24       Impact factor: 49.962

8.  Sleep, Narcolepsy, and Sodium Oxybate.

Authors:  Mortimer Mamelak
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.